AIF1 and glioma: Together, these data suggest that the increase in Iba1+ cells may be driven by the administered sTDEVs and that sTDEVs released by H-FIRE-treated glioma cells are functionally unique in promoting this infiltration compared to sTDEVs released by 0 V/cm-treated glioma cells.